Hereditary Angioedema Therapeutic Market Report

Hereditary Angioedema Therapeutic Market Analysis Report By Drug Class (Bradykinin B2 Receptor Antagonist, C1-Esterase Inhibitor), By Route of Administration, By Treatment Type, And Segment Forecasts, 2019 - 2026

Report ID: GVR-3-68038-156-6
Number of Pages: 100
Format: Electronic (PDF)

Historical Range: 2014 - 2017
Industry:Healthcare

Market Segmentation

Hereditary Angioedema Therapeutics Drug Class Outlook (Revenue, USD Million, 2014 - 2026)
- C1-esterase inhibitor
- Bradykinin B2 receptor antagonist
- Kallikrein inhibitor
- Others
Hereditary Angioedema TherapeuticsTreatment Type Outlook (Revenue, USD Million, 2014 - 2026)
- Prophylaxis
- On-demand
Hereditary Angioedema TherapeuticsRoute of Administration Outlook (Revenue, USD Million, 2014 - 2026)
- Intravenous
- Subcutaneous
- Oral
Hereditary Angioedema TherapeuticsRegional Outlook (Revenue, USD Million, 2014 - 2026)
- North America
  - North America Hereditary Angioedema Therapeutics Market, by Drug Class
    - C1-esterase inhibitor
    - Bradykinin B2 receptor antagonist
    - Kallikrein inhibitor
    - Others
  - North America Hereditary Angioedema Therapeutics Market, by Treatment Type
    - Prophylaxis
    - On-demand
  - North America Hereditary Angioedema Therapeutics Market, by Route of Administration
    - Intravenous
    - Subcutaneous
    - Oral
  - The U.S.
    - U.S. Hereditary Angioedema Therapeutics Market, by Drug Class
      - C1-esterase inhibitor
      - Bradykinin B2 receptor antagonist
      - Kallikrein inhibitor
      - Others
    - U.S. Hereditary Angioedema Therapeutics Market, by Treatment Type
      - Prophylaxis
      - On-demand
    - U.S. Hereditary Angioedema Therapeutics Market, by Route of Administration
      - Intravenous
      - Subcutaneous
      - Oral
  - Canada
    - Canada Hereditary Angioedema Therapeutics Market, by Drug Class
      - C1-esterase inhibitor
      - Bradykinin B2 receptor antagonist
      - Kallikrein inhibitor
      - Others
    - Canada Hereditary Angioedema Therapeutics Market, by Treatment Type
      - Prophylaxis
      - On-demand
    - Canada Hereditary Angioedema Therapeutics Market, by Route of Administration
      - Intravenous
      - Subcutaneous
      - Oral
- Europe
  - Europe Hereditary Angioedema Therapeutics Market, by Drug Class
    - C1-esterase inhibitor
    - Bradykinin B2 receptor antagonist
    - Kallikrein inhibitor
    - Others
  - Europe Hereditary Angioedema Therapeutics Market, by Treatment Type
    - Prophylaxis
    - On-demand
  - Europe Hereditary Angioedema Therapeutics Market, by Route of Administration
    - Intravenous
    - Subcutaneous
    - Oral
  - Germany
    - Germany Hereditary Angioedema Therapeutics Market, by Drug Class
      - C1-esterase inhibitor
      - Bradykinin B2 receptor antagonist
      - Kallikrein inhibitor
      - Others
    - Germany Hereditary Angioedema Therapeutics Market, by Treatment Type
      - Prophylaxis
      - On-demand
    - Germany Hereditary Angioedema Therapeutics Market, by Route of Administration
      - Intravenous
      - Subcutaneous
      - Oral
  - France
    - France Hereditary Angioedema Therapeutics Market, by Drug Class
      - C1-esterase inhibitor
      - Bradykinin B2 receptor antagonist
      - Kallikrein inhibitor
      - Others
    - France Hereditary Angioedema Therapeutics Market, by Treatment Type
      - Prophylaxis
      - On-demand
    - France Hereditary Angioedema Therapeutics Market, by Route of Administration
      - Intravenous
      - Subcutaneous
      - Oral
  - The U.K.
    - U.K. Hereditary Angioedema Therapeutics Market, by Drug Class
      - C1-esterase inhibitor
      - Bradykinin B2 receptor antagonist
      - Kallikrein inhibitor
      - Others
    - U.K. Hereditary Angioedema Therapeutics Market, by Treatment Type
      - Prophylaxis
      - On-demand
    - U.K. Hereditary Angioedema Therapeutics Market, by Route of Administration
      - Intravenous
      - Subcutaneous
      - Oral
  - Italy
    - Italy Hereditary Angioedema Therapeutics Market, by Drug Class
      - C1-esterase inhibitor
      - Bradykinin B2 receptor antagonist
      - Kallikrein inhibitor
      - Others
    - Italy Hereditary Angioedema Therapeutics Market, by Treatment Type
      - Prophylaxis
      - On-demand
    - Italy Hereditary Angioedema Therapeutics Market, by Route of Administration
      - Intravenous
      - Subcutaneous
      - Oral
  - Spain
    - Spain Hereditary Angioedema Therapeutics Market, by Drug Class
      - C1-esterase inhibitor
      - Bradykinin B2 receptor antagonist
      - Kallikrein inhibitor
      - Others
    - Spain Hereditary Angioedema Therapeutics Market, by Treatment Type
      - Prophylaxis
      - On-demand
    - Spain Hereditary Angioedema Therapeutics Market, by Route of Administration
      - Intravenous
      - Subcutaneous
      - Oral
  - Russia
    - Russia Hereditary Angioedema Therapeutics Market, by Drug Class
      - C1-esterase inhibitor
      - Bradykinin B2 receptor antagonist
      - Kallikrein inhibitor
      - Others
    - Russia Hereditary Angioedema Therapeutics Market, by Treatment Type
      - Prophylaxis
      - On-demand
    - Russia Hereditary Angioedema Therapeutics Market, by Route of Administration
      - Intravenous
      - Subcutaneous
      - Oral
- Asia Pacific
  - 亚太遗传性血管性水肿治疗rket, by Drug Class
    - C1-esterase inhibitor
    - Bradykinin B2 receptor antagonist
    - Kallikrein inhibitor
    - Others
  - 亚太遗传性血管性水肿治疗rket, by Treatment Type
    - Prophylaxis
    - On-demand
  - 亚太遗传性血管性水肿治疗rket, by Route of Administration
    - Intravenous
    - Subcutaneous
    - Oral
  - Japan
    - Japan Hereditary Angioedema Therapeutics Market, by Drug Class
      - C1-esterase inhibitor
      - Bradykinin B2 receptor antagonist
      - Kallikrein inhibitor
      - Others
    - Japan Hereditary Angioedema Therapeutics Market, by Treatment Type
      - Prophylaxis
      - On-demand
    - Japan Hereditary Angioedema Therapeutics Market, by Route of Administration
      - Intravenous
      - Subcutaneous
      - Oral
  - China
    - China Hereditary Angioedema Therapeutics Market, by Drug Class
      - C1-esterase inhibitor
      - Bradykinin B2 receptor antagonist
      - Kallikrein inhibitor
      - Others
    - China Hereditary Angioedema Therapeutics Market, by Treatment Type
      - Prophylaxis
      - On-demand
    - China Hereditary Angioedema Therapeutics Market, by Route of Administration
      - Intravenous
      - Subcutaneous
      - Oral
  - India
    - India Hereditary Angioedema Therapeutics Market, by Drug Class
      - C1-esterase inhibitor
      - Bradykinin B2 receptor antagonist
      - Kallikrein inhibitor
      - Others
    - India Hereditary Angioedema Therapeutics Market, by Treatment Type
      - Prophylaxis
      - On-demand
    - India Hereditary Angioedema Therapeutics Market, by Route of Administration
      - Intravenous
      - Subcutaneous
      - Oral
  - South Korea
    - South Korea Hereditary Angioedema Therapeutics Market, by Drug Class
      - C1-esterase inhibitor
      - Bradykinin B2 receptor antagonist
      - Kallikrein inhibitor
      - Others
    - South Korea Hereditary Angioedema Therapeutics Market, by Treatment Type
      - Prophylaxis
      - On-demand
    - South Korea Hereditary Angioedema Therapeutics Market, by Route of Administration
      - Intravenous
      - Subcutaneous
      - Oral
  - Australia
    - Australia Hereditary Angioedema Therapeutics Market, by Drug Class
      - C1-esterase inhibitor
      - Bradykinin B2 receptor antagonist
      - Kallikrein inhibitor
      - Others
    - Australia Hereditary Angioedema Therapeutics Market, by Treatment Type
      - Prophylaxis
      - On-demand
    - Australia Hereditary Angioedema Therapeutics Market, by Route of Administration
      - Intravenous
      - Subcutaneous
      - Oral
  - Singapore
    - Singapore Hereditary Angioedema Therapeutics Market, by Drug Class
      - C1-esterase inhibitor
      - Bradykinin B2 receptor antagonist
      - Kallikrein inhibitor
      - Others
    - Singapore Hereditary Angioedema Therapeutics Market, by Treatment Type
      - Prophylaxis
      - On-demand
    - Singapore Hereditary Angioedema Therapeutics Market, by Route of Administration
      - Intravenous
      - Subcutaneous
      - Oral
- Latin America
  - Latin America Hereditary Angioedema Therapeutics Market, by Drug Class
    - C1-esterase inhibitor
    - Bradykinin B2 receptor antagonist
    - Kallikrein inhibitor
    - Others
  - Latin America Hereditary Angioedema Therapeutics Market, by Treatment Type
    - Prophylaxis
    - On-demand
  - Latin America Hereditary Angioedema Therapeutics Market, by Route of Administration
    - Intravenous
    - Subcutaneous
    - Oral
  - Brazil
    - Brazil Hereditary Angioedema Therapeutics Market, by Drug Class
      - C1-esterase inhibitor
      - Bradykinin B2 receptor antagonist
      - Kallikrein inhibitor
      - Others
    - Brazil Hereditary Angioedema Therapeutics Market, by Treatment Type
      - Prophylaxis
      - On-demand
    - Brazil Hereditary Angioedema Therapeutics Market, by Route of Administration
      - Intravenous
      - Subcutaneous
      - Oral
  - Mexico
    - Mexico Hereditary Angioedema Therapeutics Market, by Drug Class
      - C1-esterase inhibitor
      - Bradykinin B2 receptor antagonist
      - Kallikrein inhibitor
      - Others
    - Mexico Hereditary Angioedema Therapeutics Market, by Treatment Type
      - Prophylaxis
      - On-demand
    - Mexico Hereditary Angioedema Therapeutics Market, by Route of Administration
      - Intravenous
      - Subcutaneous
      - Oral
  - Argentina
    - Argentina Hereditary Angioedema Therapeutics Market, by Drug Class
      - C1-esterase inhibitor
      - Bradykinin B2 receptor antagonist
      - Kallikrein inhibitor
      - Others
    - Argentina Hereditary Angioedema Therapeutics Market, by Treatment Type
      - Prophylaxis
      - On-demand
    - Argentina Hereditary Angioedema Therapeutics Market, by Route of Administration
      - Intravenous
      - Subcutaneous
      - Oral
- Middle East & Africa
  - Middle East & Africa Hereditary Angioedema Therapeutics Market, by Drug Class
    - C1-esterase inhibitor
    - Bradykinin B2 receptor antagonist
    - Kallikrein inhibitor
    - Others
  - Middle East & Africa Hereditary Angioedema Therapeutics Market, by Treatment Type
    - Prophylaxis
    - On-demand
  - Middle East & Africa Hereditary Angioedema Therapeutics Market, by Route of Administration
    - Intravenous
    - Subcutaneous
    - Oral
  - Israel
    - Israel Hereditary Angioedema Therapeutics Market, by Drug Class
      - C1-esterase inhibitor
      - Bradykinin B2 receptor antagonist
      - Kallikrein inhibitor
      - Others
    - Israel Hereditary Angioedema Therapeutics Market, by Treatment Type
      - Prophylaxis
      - On-demand
    - Israel Hereditary Angioedema Therapeutics Market, by Route of Administration
      - Intravenous
      - Subcutaneous
      - Oral
  - Saudi Arabia
    - Saudi Arabia Hereditary Angioedema Therapeutics Market, by Drug Class
      - C1-esterase inhibitor
      - Bradykinin B2 receptor antagonist
      - Kallikrein inhibitor
      - Others
    - Saudi Arabia Hereditary Angioedema Therapeutics Market, by Treatment Type
      - Prophylaxis
      - On-demand
    - Saudi Arabia Hereditary Angioedema Therapeutics Market, by Route of Administration
      - Intravenous
      - Subcutaneous
      - Oral
  - UAE
    - UAE Hereditary Angioedema Therapeutics Market, by Drug Class
      - C1-esterase inhibitor
      - Bradykinin B2 receptor antagonist
      - Kallikrein inhibitor
      - Others
    - UAE Hereditary Angioedema Therapeutics Market, by Treatment Type
      - Prophylaxis
      - On-demand
    - UAE Hereditary Angioedema Therapeutics Market, by Route of Administration
      - Intravenous
      - Subcutaneous
      - Oral

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
乐鱼体育手机网站入口
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2014 to 2026
Market estimates and forecast for product segments up to 2026
Regional market size and forecast for product segments up to 2026
Market estimates and forecast for application segments up to 2026
Regional market size and forecast for application segments up to 2026
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report -free of charge- including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read ourprivacy policy.